Results 81 to 90 of about 81,709 (149)

Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. [PDF]

Mil Med Res, 2022
Zhu MH, Liu ZJ, Hu QY, Yang JY, Jin Y, Zhu N, Huang Y, Shi DH, Liu MJ, Tan HY, Zhao L, Lv QY, Yi ZH, Wu FC, Li ZZ.   +14 more
europepmc   +1 more source

Corrigendum to: Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in RPE65. [PDF]

Med Genet
Lorenz B.
europepmc   +1 more source

Augmentation Therapy With Serotonin 5-HT_1A Receptor Partial Agonists on Cognitive Function in Depressive Disorders: A Systematic Review of Randomized Controlled Studies. [PDF]

Neuropsychopharmacol Rep
Yamada R, Wada A, Stickley A, Newman-Tancredi A, Sumiyoshi T.   +4 more
europepmc   +1 more source

Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic. [PDF]

Pulm Ther, 2022
Colello J, Ptasinski A, Zhan X, Kaur S, Craig T.   +4 more
europepmc   +1 more source

High-definition transcranial direct current stimulation (HD-tDCS) as augmentation therapy in late-life depression (LLD) with suboptimal response to treatment-a study protocol for a double-blinded randomized sham-controlled trial. [PDF]

Trials, 2022
Ngan STJ, Chan LK, Chan WC, Lam LCW, Li WK, Lim K, Or E, Pang PF, Poon TK, Wong MCM, Wu YKA, Cheng PWC.   +11 more
europepmc   +1 more source

ERG assessment of altered retinal function in canine models of retinitis pigmentosa and monitoring of response to translatable gene augmentation therapy. [PDF]

Doc Ophthalmol, 2021
Pasmanter N, Occelli LM, Petersen-Jones SM.   +2 more
europepmc   +1 more source

Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in <b><i>RPE65</i></b>. [PDF]

Med Genet
Lorenz B.
europepmc   +1 more source

Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis. [PDF]

BMC Pulm Med, 2021
Barjaktarevic I, Miravitlles M.
europepmc   +1 more source

Fine-tuning FAM161A gene augmentation therapy to restore retinal function. [PDF]

EMBO Mol Med
Arsenijevic Y, Chang N, Mercey O, El Fersioui Y, Koskiniemi-Kuendig H, Joubert C, Bemelmans AP, Rivolta C, Banin E, Sharon D, Guichard P, Hamel V, Kostic C.   +12 more
europepmc   +1 more source

Assessing the efficacy of Alpha₁-Proteinase inhibitor (human) augmentation therapy for Alpha₁-Antitrypsin deficiency - Related emphysema: Challenges and opportunities. [PDF]

Heliyon
Pierce LR.
europepmc   +1 more source